Cancer Supportive Care Products Market: By Cancer (Lung Cancer, Liver Cancer, Breast Cancer, Leukemia, Prostate Cancer, Ovarian Cancer, Bladder Cancer), By Therapeutic Area (Oral Mucositis And Dry Mouth, Chemotherapy Induced Nausea And Vomiting Cancer Pain, Chemotherapy Induced Anemia, Chemotherapy Induced Neutropenia, Bone Metastases), By Distriution Channel (Hospital Pharmacies, Retail Pharmacies, Compounding Pharmacies) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Cancer Supportive Care Products Market size was valued at USD 21,834.5 million in 2022 and is poised to grow at a significant CAGR of 2.5% from 2023-2029. The global market provides a detailed overview and which can be segmented by cancer, therapeutic area, distribution channel, and region. By cancer, the cancer supportive care products market has been segmented into lung cancer, liver cancer, breast cancer, leukemia, prostate cancer, ovarian cancer, and bladder cancer. By cancer, the breast cancer segment held the largest revenue share of the gastric cancer therapy market in past years and is expected to have a significant growth rate over the forecasted period due to increasing incidences of breast cancer majorly in women worldwide. By therapeutic area, the cancer supportive care products market has been segmented into oral mucositis and dry mouth, chemotherapy-induced nausea and vomiting cancer pain, chemotherapy-induced anemia, chemotherapy-induced neutropenia, and bone metastases. By therapeutic area, the chemotherapy-induced nausea and vomiting cancer pain segment held the largest revenue share of the gastric cancer therapy market in past years and is expected to have the fastest growth rate over the forecasted period. By distribution channel, the cancer supportive care products market has been segmented into hospital pharmacies, retail pharmacies, and compounding pharmacies. By distribution channel, the retail pharmacies segment held the largest revenue share of the gastric cancer therapy market in past years and is expected to have the fastest growth rate over the forecasted period due to the high demand for cancer care products.

Cancer Supportive Care Products Market Key Development:

  • In August 2020, in a late-stage study, Bristol Myers Squibb stated that Idhifa, which has been approved by the FDA for relapsed or refractory AML with an IDH2 mutation, failed to show efficacy in improving survival in the same patient population when given alongside optimum supportive treatment.
  • In September 2020, Merck presented more than 30 abstracts at the European Society for Medical Oncology (ESMO) Virtual Congress 2020.

Cancer Supportive Care Products Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

2.5%

Largest Market

North America

Fastest Growing Market

Europe
Cancer Supportive Care Products Market Dynamics

Rise in the incidence of cancer. As per the American Cancer Society, there would be 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the United States year 2019. Furthermore, Increasing the aging population leads to a cancer patient population, which increases the demand for cancer-supportive care products. According to a retrospective cohort study published in August 2020 in JAMA Network, Open titled "association of geriatric management and 90-Day postoperative mortality among patients aged 75 years and older with cancer," geriatric co-management was associated with significantly lower 90-day postoperative mortality among older cancer patients.

Key Features of the Reports

  • The cancer supportive care products market report provides granular level information about the market size, regional market share, historic market and forecast
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startups details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis in addition to recent technology advancements and innovations in the market

Cancer Supportive Care Products Market Segmentation

By Cancer
  • Lung Cancer
  • Liver Cancer
  • Breast Cancer
  • Leukemia
  • Prostate Cancer
  • Ovarian Cancer
  • Bladder Cancer
  • Others
By Therapeutic Area
  • Oral Mucositis
  • Dry Mouth
  • Chemotherapy Induced Nausea
  • Vomiting Cancer Pain
  • Chemotherapy Induced Anemia
  • Chemotherapy Induced Neutropenia
  • Bone Metastases
  • Others
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Compounding Pharmacies
By Geography

North America

  • US
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

Frequently Asked Questions

The key segments covered in the Cancer Supportive Care Products Market are technology, components, application, and end-users.

The Cancer Supportive Care Products Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

The Cancer Supportive Care Products Market key players Abbott Laboratories (U.S.), Hoffmann-La Roche Ltd. (Switzerland), AbbVie Inc. (U.S.), Arquer Diagnostics Ltd. (U.K.), Illumina, Inc. (U.S.), Qiagen (Germany), Agilent Technologies (U.S.), Merck & Co. Inc. (U.S.), Becton Dickinson and Company (U.S.), Hologic Inc. (U.S.)

1.Executive Summary
2.Global Cancer Supportive Care Products Market Introduction 
2.1.Global Cancer Supportive Care Products Market  - Taxonomy
2.2.Global Cancer Supportive Care Products Market  - Definitions
2.2.1.Cancer
2.2.2.Therapeutic Area
2.2.3.Distribution Channel
2.2.4.Region
3.Global Cancer Supportive Care Products Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Cancer Supportive Care Products Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Cancer Supportive Care Products Market  By Cancer, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. ung Cancer
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Liver Cancer
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Breast Cancer
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Leukemia
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Prostate Cancer
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Ovarian Cancer
5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Bladder Cancer
5.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
5.8. Others
5.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.8.3. Market Opportunity Analysis 
6.Global Cancer Supportive Care Products Market  By Therapeutic Area, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Oral Mucositis
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Dry Mouth
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Chemotherapy Induced Nausea
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Vomiting Cancer Pain
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Chemotherapy Induced Anemia
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Chemotherapy Induced Neutropenia
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Bone Metastases
6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
6.8. Others
6.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.8.3. Market Opportunity Analysis 
7.Global Cancer Supportive Care Products Market  By Distribution Channel, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Hospital Pharmacies
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Retail Pharmacies
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Compounding Pharmacies
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Cancer Supportive Care Products Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Cancer Supportive Care Products Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Cancer Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.ung Cancer
9.1.2.Liver Cancer
9.1.3.Breast Cancer
9.1.4.Leukemia
9.1.5.Prostate Cancer
9.1.6.Ovarian Cancer
9.1.7.Bladder Cancer
9.1.8.Others
9.2.  Therapeutic Area Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Oral Mucositis
9.2.2.Dry Mouth
9.2.3.Chemotherapy Induced Nausea
9.2.4.Vomiting Cancer Pain
9.2.5.Chemotherapy Induced Anemia
9.2.6.Chemotherapy Induced Neutropenia
9.2.7.Bone Metastases
9.2.8.Others
9.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospital Pharmacies
9.3.2.Retail Pharmacies
9.3.3.Compounding Pharmacies
9.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Cancer Supportive Care Products Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Cancer Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.ung Cancer
10.1.2.Liver Cancer
10.1.3.Breast Cancer
10.1.4.Leukemia
10.1.5.Prostate Cancer
10.1.6.Ovarian Cancer
10.1.7.Bladder Cancer
10.1.8.Others
10.2.  Therapeutic Area Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Oral Mucositis
10.2.2.Dry Mouth
10.2.3.Chemotherapy Induced Nausea
10.2.4.Vomiting Cancer Pain
10.2.5.Chemotherapy Induced Anemia
10.2.6.Chemotherapy Induced Neutropenia
10.2.7.Bone Metastases
10.2.8.Others
10.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital Pharmacies
10.3.2.Retail Pharmacies
10.3.3.Compounding Pharmacies
10.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11.Asia Pacific (APAC) Cancer Supportive Care Products Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Cancer Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.ung Cancer
11.1.2.Liver Cancer
11.1.3.Breast Cancer
11.1.4.Leukemia
11.1.5.Prostate Cancer
11.1.6.Ovarian Cancer
11.1.7.Bladder Cancer
11.1.8.Others
11.2.  Therapeutic Area Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Oral Mucositis
11.2.2.Dry Mouth
11.2.3.Chemotherapy Induced Nausea
11.2.4.Vomiting Cancer Pain
11.2.5.Chemotherapy Induced Anemia
11.2.6.Chemotherapy Induced Neutropenia
11.2.7.Bone Metastases
11.2.8.Others
11.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital Pharmacies
11.3.2.Retail Pharmacies
11.3.3.Compounding Pharmacies
11.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Cancer Supportive Care Products Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Cancer Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.ung Cancer
12.1.2.Liver Cancer
12.1.3.Breast Cancer
12.1.4.Leukemia
12.1.5.Prostate Cancer
12.1.6.Ovarian Cancer
12.1.7.Bladder Cancer
12.1.8.Others
12.2.  Therapeutic Area Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Oral Mucositis
12.2.2.Dry Mouth
12.2.3.Chemotherapy Induced Nausea
12.2.4.Vomiting Cancer Pain
12.2.5.Chemotherapy Induced Anemia
12.2.6.Chemotherapy Induced Neutropenia
12.2.7.Bone Metastases
12.2.8.Others
12.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital Pharmacies
12.3.2.Retail Pharmacies
12.3.3.Compounding Pharmacies
12.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Cancer Supportive Care Products Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Cancer Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.ung Cancer
13.1.2.Liver Cancer
13.1.3.Breast Cancer
13.1.4.Leukemia
13.1.5.Prostate Cancer
13.1.6.Ovarian Cancer
13.1.7.Bladder Cancer
13.1.8.Others
13.2.  Therapeutic Area Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Oral Mucositis
13.2.2.Dry Mouth
13.2.3.Chemotherapy Induced Nausea
13.2.4.Vomiting Cancer Pain
13.2.5.Chemotherapy Induced Anemia
13.2.6.Chemotherapy Induced Neutropenia
13.2.7.Bone Metastases
13.2.8.Others
13.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital Pharmacies
13.3.2.Retail Pharmacies
13.3.3.Compounding Pharmacies
13.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Abbott Laboratories (U.S)
14.2.2.Hoffmann-La Roche Ltd (Switzerland)
14.2.3.AbbVie Inc (U.S)
14.2.4.Arquer Diagnostics Ltd (U.K)
14.2.5.Illumina Inc (U.S)
14.2.6.Qiagen (Germany)
14.2.7.Agilent Technologies (U.S)
14.2.8.Merck & Co Inc (U.S)
14.2.9.Becton Dickinson and Company (U.S)
14.2.10.Hologic Inc (U.S)
15. Research Methodology 
16. Appendix and Abbreviations 
  • Abbott Laboratories (U.S)
  • Hoffmann-La Roche Ltd (Switzerland)
  • AbbVie Inc (U.S)
  • Arquer Diagnostics Ltd (U.K)
  • Illumina Inc (U.S)
  • Qiagen (Germany)
  • Agilent Technologies (U.S)
  • Merck & Co Inc (U.S)
  • Becton Dickinson and Company (U.S)
  • Hologic Inc (U.S)

Adjacent Markets